Staar Surgical Co [STAA] stock is trading at $18.34, up 2.34%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The STAA shares have gain 4.80% over the last week, with a monthly amount drifted -22.39%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Staar Surgical Co [NASDAQ: STAA] stock has seen the most recent analyst activity on February 12, 2025, when William Blair downgraded its rating to a Mkt Perform. Previously, Mizuho downgraded its rating to Neutral on February 12, 2025, and dropped its price target to $17. On February 12, 2025, downgrade downgraded it’s rating to Hold. BTIG Research downgraded its rating to a Neutral. Morgan Stanley downgraded its rating to a Underweight and reduced its price target to $37 on July 15, 2024. BTIG Research upgraded its rating to Buy for this stock on June 11, 2024, but kept the price target unchanged to $46. In a note dated March 11, 2024, Stifel upgraded an Buy rating on this stock and boosted its target price from $30 to $50.
Staar Surgical Co [STAA] stock has fluctuated between $13.50 and $52.68 over the past year. Currently, Wall Street analysts expect the stock to reach $54.58 within the next 12 months. Staar Surgical Co [NASDAQ: STAA] shares were valued at $18.34 at the most recent close of the market. An investor can expect a potential return of 197.6% based on the average STAA price forecast.
Analyzing the STAA fundamentals
Staar Surgical Co [NASDAQ:STAA] reported sales of 313.90M for the trailing twelve months, which represents a drop of -35.82%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 27.45, Equity is 0.05 and Total Capital is -28.71. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.74 points at the first support level, and at 17.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.25, and for the 2nd resistance point, it is at 20.17.
Ratios To Look Out For
For context, Staar Surgical Co’s Current Ratio is 5.23. As well, the Quick Ratio is 4.62, while the Cash Ratio is 2.05. Considering the valuation of this stock, the price to sales ratio is 2.88, the price to book ratio is 2.28.
Transactions by insiders
Recent insider trading involved BROADWOOD PARTNERS, L.P., 10% Owner, that happened on Mar 04 ’25 when 27953.0 shares were purchased. 10% Owner, BROADWOOD PARTNERS, L.P. completed a deal on Feb 27 ’25 to buy 0.26 million shares. Meanwhile, 10% Owner BROADWOOD PARTNERS, L.P. bought 0.25 million shares on Mar 03 ’25.
